Patents by Inventor Stephen John Martin Skinner

Stephen John Martin Skinner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Xenotransplant Compositions and Methods of Stroke Therapy
    Publication number: 20140255462
    Abstract: Disclosed are implant compositions and methods for treatment of neurological diseases of the central nervous system of a mammal.
    Type: Application
    Filed: October 8, 2013
    Publication date: September 11, 2014
    Applicant: Neurotrophincell Pty Ltd.
    Inventors: Robert Bartlett Elliott, Stephen John Martin Skinner, Alfred Vasconcellos, Dwaine Emerich, Cesar Venturina Borlongan, Christopher Edward Williams
  • Choroid plexus preparation and uses thereof
    Patent number: 8129186
    Abstract: The present invention is directed to the use of choroid plexus cells and/or choroid plexus conditioned media for enhancing the growth, survival and/or maintenance of function of non-choroid plexus cells grown in long term or short term culture.
    Type: Grant
    Filed: April 18, 2006
    Date of Patent: March 6, 2012
    Assignee: Neurotrophincell Pty, Limited
    Inventors: Robert Bartlett Elliott, Stephen John Martin Skinner, Livia Del Carmen Escobar Orellana, Christopher Thanos
  • Xenotransplant for Stroke Therapy
    Publication number: 20100310627
    Abstract: Disclosed are implant compositions and methods for treatment of neurological diseases of the central nervous system of a mammal.
    Type: Application
    Filed: August 17, 2010
    Publication date: December 9, 2010
    Applicant: NEUROTROPHINCELL PTY LTD.
    Inventors: Robert Bartlett Elliott, Stephen John Martin Skinner, Alfred Vasconcellos, Dwaine Emerich, Cesar Venturina Borlongan, Christopher Edward Williams
  • ENCAPSULATION SYSTEM
    Publication number: 20090214660
    Abstract: The present invention is directed to a composition comprising high mannuronic acid-containing alginate and a polycation having a polydispersity index of less than 1.5. The composition is particularly useful for making biocompatible microcapsules containing living cells for allo- or xeno-transplantation. Such microcapsules have enhanced durability and can maintain their structural and functional integrity over long periods of time compared to prior art alginate microcapsules.
    Type: Application
    Filed: October 24, 2006
    Publication date: August 27, 2009
    Applicant: Living Cell Products Pty Limited
    Inventors: Alfred Vasconcellos, Dwaine Emerich, Chris Thanos, Briannan Bintz, Marilyn Sandra Geaney, Stephen John Martin Skinner, Paul Lip Jin Tan
  • XENOTRANSPLANT FOR CNS THERAPY
    Publication number: 20090181064
    Abstract: A “supplementary choroid plexus” comprising preferably a xenotransplant of choroid plexus cells from a neonatal mammal provides a steady supply of trophic factors for administration to a central nervous system in need of treatment for a neurological disease. Choroid plexus cells manufacture a range of trophic factors, particularly during fetal development. This neurotrophic factor therapy may be useful in treating clinical and subclinical neurodegenerative diseases particularly those in which the choroid plexus has often become atrophic. The xenotransplant is cloaked in a protective layer (such as of alginate) capable of concealing the foreign nature of the transplant. Lateral ventricles are the preferred implantation site, from where the trophic factors are carried through the neuropil by the circulation of cerebrospinal fluid.
    Type: Application
    Filed: March 5, 2009
    Publication date: July 16, 2009
    Applicant: NEUROTROPHINCELL PTY LTD.
    Inventors: Robert Bartlett Elliott, Stephen John Martin Skinner, Christopher Edward Williams
  • CELL IMPLANTATION TO PREVENT AND/OR TREAT AUTOIMMUNE DISEASE
    Publication number: 20090162325
    Abstract: The present invention is directed to the prevention or treatment of autoimmune diseases, and in particular, of type I diabetes, by administering a therapeutically effective amount of an implantable composition comprising living choroid plexus cells.
    Type: Application
    Filed: June 7, 2006
    Publication date: June 25, 2009
    Inventors: Robert Bartlett Elliott, Stephen John Martin Skinner, Paul Lip Jin Tan
  • CHOROID PLEXUS PREPARATION AND USES THEREOF
    Publication number: 20090075375
    Abstract: The present invention is directed to the use of choroids plexus cells and/or choroids plexus conditioned media for enhancing the growth, survival and/or maintenance of function of non-choroid plexus cells grown in long term or short term culture.
    Type: Application
    Filed: September 15, 2008
    Publication date: March 19, 2009
    Applicant: Neurotrophincell Pty Limited
    Inventors: Robert Bartlett Elliott, Stephen John Martin Skinner, Livia Del Carmen Escobar Orellana, Christopher Thanos, Thorsten Gorba
  • XENOTRANSPLANT FOR CNS THERAPY
    Publication number: 20090047325
    Abstract: Disclosed are compositions and methods for the xenotransplantation treatment of neurological diseases of the central nervous system of a mammal.
    Type: Application
    Filed: October 9, 2008
    Publication date: February 19, 2009
    Applicant: NEUROTROPHINCELL PTY. LIMITED
    Inventors: Robert Bartlett Elliot, Stephen John Martin Skinner, Alfred Vasconcellos, Dwaine Emerich, Cesar Venturina Borlongan, Christopher Edward Williams
  • NOVEL METHODS OF TREATMENT AND DELIVERY MODES
    Publication number: 20080292611
    Abstract: The invention relates to a novel method of administration, and device employed in the method, for administering a treatment species to the lungs of a recipient patient. The method involves introducing the device of the invention to the venous system of the patient, the size of the treatment species being such that, upon introduction to the venous system of the patient, the device will impact in a region of a lung capillary of the patient. The treatment species gains access to the lung and/or lung epithelia due to proteases associated with the treatments species. The application of the method to the treatment of cystic fibrosis is also claimed.
    Type: Application
    Filed: June 26, 2008
    Publication date: November 27, 2008
    Applicant: Living Cell Products Pty Limited
    Inventors: Robert Bartlett Elliott, Stephen John Martin Skinner
  • Choroid Plexus Preparation and Uses Thereof
    Publication number: 20080286864
    Abstract: The present invention is directed to the use of choroid plexus cells and/or choroid plexus conditioned media for enhancing the growth, survival and/or maintenance of function of non-choroid plexus cells grown in long term or short term culture.
    Type: Application
    Filed: April 18, 2006
    Publication date: November 20, 2008
    Applicant: Neurotrophincell Pty Limited
    Inventors: Robert Bartlett Elliott, Stephen John Martin Skinner, Livia Del Carmen Escobar Orellana, Christopher Thanos
  • Porcine Islets Cultured With Porcine Sertoli Cells For Xenotransplantation
    Publication number: 20080254090
    Abstract: Aggregates and their method of preparation suitable for implantation into a recipient in order to produce insulin in vivo. The methods involve culturing islet cells isolated from the pancreas of donor piglets with isolated Sertoli cells from the testes of donor piglets. A preferred period of culturing is 5 days and may be followed by a purification procedure.
    Type: Application
    Filed: June 24, 2004
    Publication date: October 16, 2008
    Applicant: DIABCELL PTY LIMITED
    Inventors: Stephen John Martin Skinner, Robert Bartlett Elliott, Livia Del Carmen Escobar Orellana
  • CELL IMPLANTATION TO PREVENT AND/OR TREAT HEARING LOSS
    Publication number: 20080119909
    Abstract: The present invention is directed to the prevention or treatment of sensorineural hearing loss by administering a therapeutically effective amount of an implantable composition comprising encapsulated living choroid plexus cells.
    Type: Application
    Filed: March 6, 2007
    Publication date: May 22, 2008
    Applicants: NEUROTROPHINCELL PTY LIMITED, LIVING CELL TECHNOLOGIES PTY LIMITED
    Inventors: Stephen John Martin Skinner, Marilyn Sandra Geaney, Paul Lip Jin Tan, Robert Keith Shepherd, Lisa Narelle Pettingill, Jacqueline Kate Andrew, Christopher Thanos, Dwaine Emerich
  • Preparation for biotransplantation and xenotransplantion and uses thereof
    Publication number: 20040213768
    Abstract: Method of preparing and administering a treatment species to a mammalian recipient, the treatment species including one or more of:
    Type: Application
    Filed: January 15, 2004
    Publication date: October 28, 2004
    Inventors: Robert Bartlett Elliott, Stephen John Martin Skinner, Christopher Edward Williams